会議要約から,ランダム化対照試験のための全長ジャーナル記事への移行
Mustafa Toma1, Finlay A McAlister, Liza Bialy
1The Division of General Internal Medicine, University of Alberta, Edmonton, Alberta, Canada.
JAMA
|March 16, 2006
まとめ
科学的会合で発表される遅発のランダム化対照試験 (RCT) は,より大きく,より早く公表され,好ましい結果を報告する可能性が低い. しかし,抽象版と完全版の発表結果の間の不一致は,すべてのRCTに共通しています.
科学分野:
- 心臓病学 心臓病学
- クリニック・トライアル 臨床試験
- 科学的出版物 科学的出版物
背景:
- 科学会議のプレゼンテーションは,公表された研究と異なる場合があります.
- 公開の運命と,遅めのセッションからのランダム化対照試験 (RCT) の一貫性は十分に研究されていません.
- 出版パターンを理解することは,正確な科学的解釈に不可欠です.
研究 の 目的:
- 大規模な科学会議の他のセッションと比較して,遅めのセッションで提示されたランダム化制御試験 (RCT) を比較する.
- これらのRCTの発表の運命を評価し,抽象と全長記事の間の結果の一貫性を評価する.
主な方法:
- アメリカン・カレッジ・オブ・カーディオロジーの科学会議 (1999-2002) の手作業で検索した抽象文書とウェブサイトで,RCTを特定しました.
- 電子データベースを利用して,その後の完全版の出版物を特定しました.
- 出版率,出版までの時間,および概要と論文間の有効性推定値の一貫性を比較した.
主要な成果:
- 遅刻したRCTはより大きく,設計論文が掲載される可能性が高く,出版時に品質が高くなりました.
- 遅めのセッションでのRCTは,他のセッションでのRCTよりも頻繁に,より早く出版されました.
- 抽象と公表の有効性推定値の差異は,公表されたRCTの41%で発生し,遅延および他のセッションでは同様の割合でした.
結論:
- ラテブレーキング試験は,より大きなサイズと早期公開を含む明確な特徴を示しますが,必ずしもより高い精度ではありません.
- 提示された結果と公表された結果の間の不一致は,遅刻した試験でも一般的な問題です.
- すべてのランダム化対照試験では,抽象的および完全な出版データの慎重な比較が必要である.
関連する概念動画
Randomized Experiments
6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.3K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Blinding
2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407


